Ventas, Inc. Stock

Equities

VTR

US92276F1003

Specialized REITs

Real-time Estimate Cboe BZX 12:29:41 2024-04-22 pm EDT 5-day change 1st Jan Change
42.77 USD -0.83% Intraday chart for Ventas, Inc. +1.28% -14.17%
Sales 2024 * 4.8B Sales 2025 * 5.07B Capitalization 17.37B
Net income 2024 * -534M Net income 2025 * -262M EV / Sales 2024 * 6.37 x
Net Debt 2024 * 13.21B Net Debt 2025 * 13.23B EV / Sales 2025 * 6.03 x
P/E ratio 2024 *
-33.4 x
P/E ratio 2025 *
-55.1 x
Employees 486
Yield 2024 *
4.28%
Yield 2025 *
4.46%
Free-Float 99.35%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.15%
1 week+0.70%
Current month-0.94%
1 month-1.78%
3 months-10.24%
6 months+3.11%
Current year-13.46%
More quotes
1 week
41.45
Extreme 41.45
43.37
1 month
41.45
Extreme 41.45
44.03
Current year
41.45
Extreme 41.45
50.61
1 year
39.33
Extreme 39.33
50.99
3 years
35.33
Extreme 35.33
64.02
5 years
13.35
Extreme 13.345
75.40
10 years
13.35
Extreme 13.345
81.93
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 98-12-31
Director of Finance/CFO 56 14-10-26
Chief Tech/Sci/R&D Officer - 19-01-24
Members of the board TitleAgeSince
Director/Board Member 59 22-03-06
Director/Board Member 63 11-05-11
Director/Board Member 55 20-07-05
More insiders
Date Price Change Volume
24-04-22 42.77 -0.83% 318 321
24-04-19 43.13 +1.15% 1,690,529
24-04-18 42.64 +0.97% 1,860,840
24-04-17 42.23 +1.32% 1,645,602
24-04-16 41.68 -1.33% 1,577,788

Delayed Quote Nyse, April 19, 2024 at 04:00 pm EDT

More quotes
Ventas, Inc. specializes in owning and managing healthcare and medical-residential facilities. At the end of 2022, the group's portfolio included 1,237 assets consisting primarily of senior housing (802), medical office buildings (313), rehabilitation and long-term acute care facilities (36), laboratories and research facilities (32), skilled nursing facilities (16), medical and surgical facilities (13). Net sales are distributed geographically as follows: the United States (88.5%), Canada (10.9%) and the United Kingdom (0.6%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
43.13 USD
Average target price
52.47 USD
Spread / Average Target
+21.66%
Consensus